Liver cancer is one of the world's deadliest cancers, and most cases are linked to chronic viral hepatitis. Yet scientists ...

Researchers have identified a promising antiviral compound that blocks hepatitis E replication in early studies. Because it ...

Hepatitis C infections often hide for years before patients begin experiencing symptoms.

Returning to drinking after alcohol-associated hepatitis (AH) is closely related to recurrent liver disease and death. Of those hospitalized for AH, 30% die within 90 days. Among the survivors, ...

Reclassifying vaccines as shared clinical decision-making creates an additional financial risk. If ACIP no longer ...

Scientists have identified a potential new weapon against hepatitis E, a virus with no approved treatment and tens of ...

Only one in three Americans who have hepatitis C virus (HCV) infection receive curative antiviral drugs, according to a ...

Hepatitis E is responsible for infecting the millions and causing the death of 70,000 people annually. The worst thing is ...

In February, a small biotech company reached a breakthrough with the FDA, agreeing to a clinical trial plan. The problem: The ...

Hepatitis B immunoglobulin (HBIG) injections can provide short-term protection against the hepatitis B virus. They may benefit people who have experienced recent exposure. Some people get acute ...

Across the globe, some 71 million people are living with a chronic hepatitis C infection, according to the World Health Organization (WHO). (1) Though no vaccine exists for hepatitis C, medications ...

A case of hepatitis A has been detected in the province of Padua. This was announced today by the Ulss 6 Euganea health ...